AMRX
Amneal·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AMRX fundamentals
Amneal (AMRX) released its earnings on Oct 30, 2025: revenue was 785.00M (YoY +11.75%), beat estimates; EPS was 0.17 (YoY +6.25%), beat estimates.
Revenue / YoY
785.00M
+11.75%
EPS / YoY
0.17
+6.25%
Report date
Oct 30, 2025
AMRX Earnings Call Summary for Q3,2025
- Q3 Growth: $785M revenue (+12% YoY), $160M EBITDA, driven by 8% Specialty growth and 24% AvKARE expansion.
- Key Launches: CREXONT (80% IR prescriptions), BREKIYA (first self-administered migraine autoinjector), and 17 new Affordable Medicines products.
- Biosimilar Momentum: Xolair BLA filed, 6 biosimilars by 2027, and FDA guidance accelerating development timelines.
- Financial Strength: 9% EBITDA growth, net leverage 3.7x, and $300M+ cash flow.
- Strategic Focus: Vertical biosimilar integration, 20+ new product launches/year, and $500M+ peak sales potential for CREXONT.
EPS
Revenue
Revenue & Expenses
AMRX has released its 2025 Q3 earnings report, with revenue of 784.51M, reflecting a YoY change of 11.68%, and net profit of 18.13M, showing a YoY change of 54.22%. The Sankey diagram below clearly presents AMRX's revenue sources and cost distribution.
Key Indicators
Amneal (AMRX) key financial stats and ratios, covering profitability, financial health, and leverage.
Amneal (AMRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Amneal (AMRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Amneal (AMRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Amneal (AMRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Amneal (AMRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Amneal's earnings call?Did Amneal beat or miss consensus estimates last quarter?What guidance did Amneal's management provide for the next earnings period?What is the revenue and EPS growth rate for Amneal year over year?What factors drove the changes in Amneal's revenue and profit?What were the key takeaways from Amneal’s earnings call?What is Amneal's latest dividend and current dividend yield?What does Amneal do and what are its main business segments?
